Market Research Logo

Global Prostate Cancer Epidemiology and Patient Flow Analysis - 2017

Global Prostate Cancer Epidemiology and Patient Flow Analysis - 2017

Fore Pharma announced the results of its Prostate Cancer patients study in a new report ‘Global Prostate Cancer Epidemiology and Patient Flow Analysis - 2017’. The report provides insights into Prostate Cancer epidemiology, Prostate Cancer diagnosed patients, and Prostate Cancer treatment rate for top seven pharmaceutical markets. The study measures key indicators such as prevalence of Prostate Cancer derived from epidemiological analysis, percentage of patients diagnosed with Prostate Cancer, and percentage of patients treated with a therapy.

The study helps executives estimate Prostate Cancer market potential, assess unmet need, develop drug forecasting models, and build population-based health management frameworks. The information presented in this study is used to evaluate market opportunities, effectively identify target patient population, and align marketing decisions.

The report provides estimates and forecasts of Prostate Cancer prevalence, Prostate Cancer diagnosis rate, and Prostate Cancer treatment rate for the period 2016 - 2025. The information is presented by leading geographies including the US, Germany, France, Spain, Italy, UK, and Japan. The study design is based on interpretation and analysis of data collected from physicians via primary interviews, registries, scientific journals, literatures, government databases and other secondary sources.

Key Features of the Report:

  • Prostate Cancer Patient Flow
  • Prostate Cancer Prevalence
  • Prostate Cancer Diagnosed Patients
  • Prostate Cancer Treated Patients


1. Prostate Cancer: Disease Definition
2. Global Prostate Cancer Patient Flow
2A. Global Prostate Cancer Prevalence
2B. Global Prostate Cancer Diagnosed Patients
2C. Global Prostate Cancer Treated Patients
3. Prostate Cancer Patient Flow in the US
3A. Prostate Cancer Prevalence in the US
3B. Prostate Cancer Diagnosed Patients in the US
3C. Prostate Cancer Treated Patients in the US
4. Prostate Cancer Patient Flow in Europe
4A. Prostate Cancer Prevalence in Europe
4B. Prostate Cancer Diagnosed Patients in Europe
4C. Prostate Cancer Treated Patients in Europe
5. Prostate Cancer Patient Flow in Germany
5A. Prostate Cancer Prevalence in Germany
5B. Prostate Cancer Diagnosed Patients in Germany
5C. Prostate Cancer Treated Patients in Germany
6. Prostate Cancer Patient Flow in France
6A. Prostate Cancer Prevalence in France
6B. Prostate Cancer Diagnosed Patients in France
6C. Prostate Cancer Treated Patients in France
7. Prostate Cancer Patient Flow in Spain
7A. Prostate Cancer Prevalence in Spain
7B. Prostate Cancer Diagnosed Patients in Spain
7C. Prostate Cancer Treated Patients in Spain
8. Prostate Cancer Patient Flow in Italy
8A. Prostate Cancer Prevalence in Italy
8B. Prostate Cancer Diagnosed Patients in Italy
8C. Prostate Cancer Treated Patients in Italy
9. Prostate Cancer Patient Flow in UK
9A. Prostate Cancer Prevalence in UK
9B. Prostate Cancer Diagnosed Patients in UK
9C. Prostate Cancer Treated Patients in UK
10. Prostate Cancer Patient Flow in Japan
10A. Prostate Cancer Prevalence in Japan
10B. Prostate Cancer Diagnosed Patients in Japan
10C. Prostate Cancer Treated Patients in Japan
11. Research Methodology
List of Tables
Table 1: Global Prostate Cancer Patient Flow, 2016
Table 2: Global Prostate Cancer Patient Flow Forecast, 2016 - 2025
Table 3: Prostate Cancer Patient Flow in the US, 2016
Table 4: Prostate Cancer Patient Flow Forecast in the US, 2016 - 2025
Table 5: Prostate Cancer Patient Flow in Europe, 2016
Table 6: Prostate Cancer Patient Flow Forecast in Europe, 2016 - 2025
Table 7: Prostate Cancer Patient Flow in Germany, 2016
Table 8: Prostate Cancer Patient Flow Forecast in Germany, 2016 - 2025
Table 9: Prostate Cancer Patient Flow in France, 2016
Table 10: Prostate Cancer Patient Flow Forecast in France, 2016 - 2025
Table 11: Prostate Cancer Patient Flow in Spain, 2016
Table 12: Prostate Cancer Patient Flow Forecast in Spain, 2016 - 2025
Table 13: Prostate Cancer Patient Flow in Italy, 2016
Table 14: Prostate Cancer Patient Flow Forecast in Italy, 2016 - 2025
Table 15: Prostate Cancer Patient Flow in UK, 2016
Table 16: Prostate Cancer Patient Flow Forecast in UK, 2016 - 2025
Table 17: Prostate Cancer Patient Flow in Japan, 2016
Table 18: Prostate Cancer Patient Flow Forecast in Japan, 2016 - 2025
List of Figures
Figure 1: Global Prostate Cancer Patient Flow, 2016
Figure 2: Global Prostate Cancer Patient Flow Forecast, 2016 - 2025
Figure 3: Prostate Cancer Patient Flow in the US, 2016
Figure 4: Prostate Cancer Patient Flow Forecast in the US, 2016 - 2025
Figure 5: Prostate Cancer Patient Flow in Europe, 2016
Figure 6: Prostate Cancer Patient Flow Forecast in Europe, 2016 - 2025
Figure 7: Prostate Cancer Patient Flow in Germany, 2016
Figure 8: Prostate Cancer Patient Flow Forecast in Germany, 2016 - 2025
Figure 9: Prostate Cancer Patient Flow in France, 2016
Figure 10: Prostate Cancer Patient Flow Forecast in France, 2016 - 2025
Figure 11: Prostate Cancer Patient Flow in Spain, 2016
Figure 12: Prostate Cancer Patient Flow Forecast in Spain, 2016 - 2025
Figure 13: Prostate Cancer Patient Flow in Italy, 2016
Figure 14: Prostate Cancer Patient Flow Forecast in Italy, 2016 - 2025
Figure 15: Prostate Cancer Patient Flow in UK, 2016
Figure 16: Prostate Cancer Patient Flow Forecast in UK, 2016 - 2025
Figure 17: Prostate Cancer Patient Flow in Japan, 2016
Figure 18: Prostate Cancer Patient Flow Forecast in Japan, 2016 - 2025

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report